Publications by authors named "L Veneti"

Background: Due to changes in testing policy and increased use of rapid tests, other indicators for SARS-CoV-2 infections are needed to monitor vaccine effectiveness (VE). We aimed to estimate VE against COVID-19 sick leave (> 3 days, certified by a medical professional) among employed individuals (25-64-years-old) in Norway.

Methods: We performed a nationwide cohort study by collating data from the Emergency preparedness register for COVID-19.

View Article and Find Full Text PDF
Article Synopsis
  • During the early COVID-19 pandemic in Norway, social distancing measures led to a significant reduction in the number of daily social contacts, particularly among younger adults, with a decline of 67-73% compared to pre-pandemic levels.
  • *The study involved online surveys of a representative sample of Norwegian adults conducted from April to September 2020, collecting data on nearly 22,000 contacts.
  • *Despite relaxations of social distancing over time, the patterns of social interaction remained stable, indicating continued limited contact in community settings versus baseline measurements.*
View Article and Find Full Text PDF

Background: SARS-CoV-2 reinfection rates have been shown to vary depending on the circulating variant, vaccination status and background immunity, as well as the time interval used to identify reinfections. This study describes the frequency of SARS-CoV-2 reinfections in Norway using different time intervals and assesses potential factors that could impact the risk of reinfections during the different variant waves.

Methods: We used linked individual-level data from national registries to conduct a retrospective cohort study including all cases with a positive test for SARS-CoV-2 from February 2020 to January 2022.

View Article and Find Full Text PDF

Background: Co-circulation of SARS-CoV-2 and influenza virus can lead to double epidemics and increased pressure on health systems. To evaluate the effect of both vaccines, we estimated the adjusted vaccine effectiveness (aVE) of influenza and Covid-19 vaccines against related severe disease in the elderly population in Norway during the 2022/2023 season.

Methods: In this population-based cohort study, we included data from the Emergency preparedness register for Covid-19 (Beredt C19) on all individuals ≥ 65 years living in Norway between 3 October 2022 and 20 June 2023.

View Article and Find Full Text PDF

Several SARS-CoV-2 variants that evolved during the COVID-19 pandemic have appeared to differ in severity, based on analyses of single-country datasets. With decreased testing and sequencing, international collaborative studies will become increasingly important for timely assessment of the severity of new variants. Therefore, a joint WHO Regional Office for Europe and ECDC working group was formed to produce and pilot a standardised study protocol to estimate relative case-severity of SARS-CoV-2 variants during periods when two variants were co-circulating.

View Article and Find Full Text PDF